Sort
64,565 grants matching “drug discovery”
Monoclonal Immunoprotectants for Select Agents Toxins (Mab-SAT)
$991,375Larry Zeitlin · Mapp Biopharmaceutical, Inc. · U01 · FY2009 · AI
A computational platform to improve the prioritization of drugs and target genes for therapeutic intervention
$991,290Kriston Lyle McGary · Genetic Networks, Llc · R44 · FY2019 · TR
Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV_AIDS
$991,186Thomas Edward Smithgall · Fox Chase Chemical Diversity Center, Inc · R42 · FY2017 · GM
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
$990,946Jay L Rothstein · Immunext, Inc. · R44 · FY2021 · AI
Therapeutic Antibodies for CMV
$990,935Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2014 · AI
Therapeutic Antibodies for CMV
$990,877Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2015 · AI
Selection of a lead LPAR1 antagonist for treatment of diabetic neuropathy
$990,691Graham Beaton · Epigen Biosciences, Inc. · R44 · FY2022 · DK
AIR Option 2: Research Alliance - Ecosystem for Biophotonic Innovation (EBI) Building Sustainability
$990,573Dennis L Matthews · University Of California-Davis · · FY2013 · TIP
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
$990,528Mayland F Chang · University Of Notre Dame · R01 · FY2014 · AI
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
$990,493Christie G. Brouillette · University Of Alabama At Birmingham · U01 · FY2008 · AI
A method for preparing unbiased miRNA sequencing libraries (miR-ACS)
$990,251Sergei A Kazakov · Somagenics, Inc. · R44 · FY2016 · HG
PDE4B Inhibitors For Treating Major Depression
$989,992Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2014 · MH
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$989,984Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Informatics Tools for High-Throughput Sequences Data Analysis
$989,800Eric Banks · Broad Institute, Inc. · U01 · FY2014 · HG
IGF::OT::IGF: PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA. N01DA-17-8932.
$989,205Patrick Beardsley · Virginia Commonwealth University · N01 · FY2019 · DA
Improved bacterial strains for therapeutic DNA and protein production
$989,190Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2009 · GM
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease
$988,940Russell Dahl · Neurodon Llc · R42 · FY2020 · AG
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
$988,840Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2021 · AI
Developmental Funds
$988,726Stanton L Gerson · Case Western Reserve University · P30 · FY2021 · CA
Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)
$988,679Kenneth W Turteltaub · University Of Calif-Lawrnc Lvrmr Nat Lab · P41 · FY2019 · GM
InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation
$988,414Bill Thelin · Altis Biosystems, Inc. · R44 · FY2023 · TR
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
$988,293Michelle M. Butler · Microbiotix, Inc · R44 · FY2015 · AI
Mechanisms of Cell Regulation and Manipulation by the Ubiquitin System
$988,057Mark Hochstrasser · Yale University · R35 · FY2025 · GM
Novel Biguanides to Treat Type 2 Diabetes
$987,938Ken W Batchelor · Novatarg, Inc. · R44 · FY2016 · DK
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$987,822Justin Kawika Ichida · University Of Southern California · R01 · FY2023 · NS